Navigation Links
CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
Date:10/27/2008

eeks O, 2 and 4, then CIMZIA 200 mg together with MTX every two weeks; 246 patients received CIMZIA 400 mg together with MTX every two weeks; 127 patients received placebo together with MTX every two weeks.

In all arms of the study, the dose of methotrexate was 10mg per week or greater. Patients were assessed for improvement in signs and symptoms of RA. The primary endpoint for the study RAPID 2 was ACR20 responder rate at week 24.

In both studies, CIMZIA given at a dosage of 200mg every two weeks produced similar clinical results as a dosage of 400mg every two weeks.

(a) ACR (American College of Rheumatology) response scores measure improvement in the tender and swollen joint count and also include assessment of the following five parameters: patient's global assessment, physician's global assessment, patient's assessment of pain, degree of disability, and level of acute-phase reactant. ACR20 is achieved when there is 20% improvement in the tender and swollen joint count as well as a 20% improvement in at least three of the five parameters. ACR50 & ACR70 are an extension of these criteria corresponding to a 50% and 70% improvement respectively. (1)

(b) Modified Total Sharp Scores (mTSS) is a measurement used to assess changes in bone erosion and joint-space narrowing measured by X-ray. A smaller change in mTSS reflects less progression of joint damage. (2)

Open-Label Study to RAPID 1 (028)

The Phase III, open-label extension (OLE) study to RAPID 1 is investigating the long-term efficacy and safety of subcutaneous CIMZIA (400 mg every 2 weeks) together with methotrexate in the treatment of signs and symptoms and in the prevention of joint damage in patients with active RA. Patients completing RAPID 1 through 52 weeks (completers), or who were ACR20 nonresponders at Week 12 (confirmed at Week 14) and were to be withdrawn from the study at Week 16 (withdrawers), could continue in the 028 study. The open-label extension study c
'/>"/>

SOURCE UCB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohns Disease Patients
2. CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohns Patients
3. Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohns Disease
4. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
5. Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients
6. Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project
7. IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP)
8. Fralex provides update on timing of interim analysis results
9. Vanda Pharmaceuticals Provides Update on Iloperidone
10. Study Demonstrates That AHCC(R) Provides Immune Enhancement Against the West Nile Virus
11. Study Reveals Novel LCD Solution Provides Significant Benefits Versus Calcipotriol In Treatment Of Moderate Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014  As the Medical Affairs, ... many leaders in this area are exploring methods to ... The Medical Affairs Consortium at Best Practices, LLC is ... sharing insights about the key challenges they face. The ... solutions through three virtual roundtable discussions where leaders discuss ...
(Date:8/22/2014)... -- MC Medical, a subsidiary of Mitsubishi Corporation (MCM), and ... medical device company, have formally agreed to an ... system in Japan . It is anticipated ... Japan in the latter half of 2015. ... portfolio in endoscopic surgery market in Japan ...
(Date:8/22/2014)... ., Aug. 22, 2014  Research presented at the 29 ... being developed by Hera Therapeutics Inc. combats three types of ... all cervical cancer. When tested in several cultured ... and HPV-11 cells, according to Louise T. Chow , ... findings at the Seattle conference. The ...
Breaking Medicine Technology:Best Practices' Medical Affairs Consortium Survey Has Achieved Strong Participation 2MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer 2
... 26 Todd Bluedorn, chief executive officer of Lennox International ... at the J.P. Morgan HVAC Conference on Thursday, May 28 ... presentation materials can be accessed on the company,s website at ... archived for 60 days. The webcast can also be ...
... Health, Inc. (TH) is pleased to announce its involvement in ... Komen Foundation. TH,s collaborator, Duke University , was ... million of investment by the foundation in 2009 to further ... cancer.The Susan G. Komen for the Cure(R) is a nonprofit ...
Cached Medicine Technology:Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R) 2Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R) 3
(Date:8/22/2014)... 22, 2014 Natural Clear Vision , ... restore his own vision from legally blind to perfect 20/20 ... investigative review. , “There is a huge portion of ... everyday function, and most people just think that’s the way ... surgery that can be pretty risky at times,” reports Michaels. ...
(Date:8/22/2014)... deletion in advanced non-small cell lung cancer (NSCLC) ... in epidermal growth factor receptor (EGFR) tyrosine kinase ... BIM deletion independently predicts overall survival (OS) of ... activate the programmed cell death also known as ... been detected in 12.8% of the Asian population ...
(Date:8/22/2014)... Rheumatoid arthritis (RA), a complex autoimmune disease that ... patients to not only cope with pain, disability ... as disrupted work, family life and marital functioning. ... residual pain and disability is common. In addition, ... high cost or side effects. Because of this, ...
(Date:8/22/2014)... London, UK (PRWEB) August 22, 2014 ... more magnetic for some clinical applications due to ... of the emerging innovations in ultrasound, such as ... imaging, are expected to keep the market moving ... as increasing mobility can enhance not only the ...
(Date:8/22/2014)... Mueller Sports Medicine is excited to ... new product that provides non-drug instant relief for plantar ... you heal. The package includes 7 days of relief, ... – it is not kinesiology tape. It’s made in ... for Plantar Fasciitis is a breakthrough in the ...
Breaking Medicine News(10 mins):Health News:Natural Clear Vision: Review Exposes Kevin Richardson’s Program for Restoring Vision Naturally 2Health News:Deletion predicts survival in advanced non-small cell lung cancer 2Health News:Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 3Health News:Mueller Introduces FasciaDerm® PFTape™ System for Plantar Fasciitis 2
... New York City has discovered that chronic pain occurs as ... colleagues were studying chronic pain at the molecular and cellular ... and the neurons becomes excited and begin to send signals ... the stimulus is removed the nerves become dormant and there ...
... mantids – that is, the female praying mantid eats ... possibility that males may also have something to gain ... In a paper in the August issue of The ... male risk-taking behavior in a praying mantis by altering ...
... facial transplant patient was discharged for a week after undergoing ... , ,Li Guoxing, 30, who had not seen his wife ... Xijing Hospital returned home Friday for a week-long visit to ... part of his face is alive and Li has been ...
... most common medical condition, chronic widespread pain is ... associated with fatigue, depression and poor sleep.// ... cancer patients deveolping FM like symptoms after treatment ... studies have shown contradictory results. A new study ...
... tested HIV positive was tied to his bedpost at the Meerut ... April after committing a robbery. He tested HIV positive only last ... College, which proved to be hopelessly inadequate to deal with his ... ago when a blood test confirmed he was HIV positive. He ...
... Alma Garcia, 41, were well aware of the toll ... was suffering from high blood pressure, diabetes and thyroid ... ,When they scheduled their gastric bypass surgeries at ... 2006, they joined a growing number of severely overweight ...
Cached Medicine News:Health News:Insufficent Anti-inflammatoy Proteins Leads to Chronic Pain 2Health News:Weight-Loss Surgeries Changing Lives 2Health News:Weight-Loss Surgeries Changing Lives 3Health News:Weight-Loss Surgeries Changing Lives 4
PosiBlot 30-30 Pads...
... VacuGene XL Vacuum Blotting System ... gels up to 20 30 ... Efficient and reproducible transfers improve blotting ... in the unit. Precise vacuum control ...
... Pens-Using a proprietary and patented technology, ADI ... called Antigen-Antibody pens-TM, that will allow researchers ... in any form or shape or size. ... to see antigen being written on the ...
... Advantages of using the Antigen-Antibody Pens-Using ... designed and developed specialized fountain pens, called ... deliver or write/mark the blotting membranes in ... specially formulated antigen-bonded colored dyes helps to ...
Medicine Products: